CIM
TMO icon

Cambria Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Cambria Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
5,532
+1,390
+34% +$667K 0.14% 174
2026
Q1 		$2.04M Sell
4,142
-284
-6% -$154K 0.11% 163
2025
Q4 		$2.56M Buy
4,426
+2,936
+197% +$1.66M 0.15% 165
2025
Q3 		$723K Buy
+1,490
New +$694K 0.04% 273
2015
Q4 		– Sell
-79
Closed -$10K – 262
2015
Q3 		$10K Buy
+79
New +$10.3K ﹤0.01% 274

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cambria Investment Management's TMO Position: Q2 2026 in Review

Cambria Investment Management increased its Thermo Fisher Scientific (TMO) stake by 34% in Q2 2026, buying an estimated $667K and bringing the position to 5,532 shares worth $2.77M. The position accounts for 0.14% of the portfolio, ranked #174.

Cambria Investment Management first reported a position in TMO in Q3 2015 and has held it in 5 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cambria Investment Management held 5,532 shares of Thermo Fisher Scientific worth $2.77M as of Q2 2026.
  • Cambria Investment Management bought 1,390 Thermo Fisher Scientific shares in Q2 2026, an estimated $667K.
  • Thermo Fisher Scientific made up 0.14% of Cambria Investment Management's portfolio in Q2 2026, its #174 holding.
  • Cambria Investment Management first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 5 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.